Problem
80% of clinical trials miss recruitment targets, delaying new treatments.

Finds the right patients for clinical trials in days instead of months, using hospital records with privacy built in.
Eight out of ten clinical trials miss their recruitment deadline, which delays new medicines and costs sponsors millions. Tessera reads de-identified hospital records to find patients who match a trial's criteria and alerts their doctors, who decide whether to suggest the trial.
Patient data never leaves the hospital: our software runs inside each hospital's own systems and only shares counts and alerts. We started in Singapore and are expanding to Malaysia, Thailand and Australia.
80% of clinical trials miss recruitment targets, delaying new treatments.
Software inside hospitals that matches patients to trials and alerts their doctors.
Pharmaceutical companies and research organisations running trials in Asia-Pacific. Patient recruitment services are a USD 4bn market.
Fee per trial plus a fee per enrolled patient, paid by trial sponsors. From USD 40,000 per trial.
Recruitment agencies, TriNetX, Deep 6 AI. Our software runs inside the hospital, which wins approvals faster.
Add 10 hospitals a year across ASEAN and Australia.
Raising USD 3m seed. Hospital integrations (50%), regulatory team (25%), sales in Australia (25%).
6 hospitals connected
Recruitment time cut from 9 months to 6 weeks in two oncology trials
Contracts with 3 global pharmaceutical companies
Approved by hospital ethics boards in Singapore and Malaysia
80% of clinical trials miss recruitment targets, delaying new treatments.
Software inside hospitals that matches patients to trials and alerts their doctors.
Pharmaceutical companies and research organisations running trials in Asia-Pacific.
Patient recruitment services are a USD 4bn market.
Add 10 hospitals a year across ASEAN and Australia.
Fee per trial plus a fee per enrolled patient, paid by trial sponsors.
From USD 40,000 per trial.
Recruitment agencies, TriNetX, Deep 6 AI.
Our software runs inside the hospital, which wins approvals faster.
Raising USD 3m seed.
Hospital integrations (50%), regulatory team (25%), sales in Australia (25%).
Tessera Health is led by Mei Lin Tan (Co-founder & CEO), Yasmin Bianchi (Co-founder & CTO), Adam Romero (Chief Operating Officer). The team combines deep industry experience with a track record of shipping products customers love.

Co-founder & CEO
Mei Lin founded Tessera Health and leads strategy, fundraising and the team. Previously spent six years at a Big Four consultancy.
Co-founder & CTO
Yasmin leads the technology and engineering team. Previously built payment systems at a European fintech.
LinkedIn profileChief Operating Officer
Adam runs day-to-day operations and customer delivery. Former product manager at a global e-commerce company.
Head of Product
Iris owns the product roadmap and user research. Holds a PhD in engineering and has two patents.
LinkedIn profileNo questions yet
Be the first to ask Tessera Health a question. Answers are public.
$3,000,000
for 10% equity · min $100,000